Latest Sulfoxides Stories

Takeda Pharmaceuticals North America, Inc., (Takeda) announced the DEXILANT (dexlansoprazole) product labeling now includes information from a study in healthy subjects demonstrating that DEXILANT had no clinically important effect on exposure to the active metabolite of clopidogrel or clopidogrel-induced platelet inhibition. No dose adjustment of clopidogrel is necessary when administered with an approved dose of DEXILANT. DEXILANT is a proton pump inhibitor (PPI) indicated for the...

DEERFIELD, Ill., Nov. 17, 2011 /PRNewswire/ -- Today, Takeda Pharmaceuticals North America, Inc., (Takeda) announced the DEXILANT (dexlansoprazole) product labeling now includes information from a study in healthy subjects demonstrating that DEXILANT had no clinically important effect on exposure to the active metabolite of clopidogrel or clopidogrel-induced platelet inhibition. No dose adjustment of clopidogrel is necessary when administered with an approved dose of DEXILANT. DEXILANT is a...

NEXIUM® Prescription Benefit cards now made available online at nexiumsupport.ca To view the Enriched Media Release, click here: http://smr.newswire.ca/en/sti/sti-enables-astrazeneca-to-allow-ongoing-choice-for HALIFAX, Sept. 9, 2011 /PRNewswire/ - Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in the patient's choice...

SEATTLE, Aug. 10, 2011 /PRNewswire/ -- The following statement is being issued by GCG Inc., Notice Administrator regarding the Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Docket No. 05-0269. If You Purchased the Drug Nexium® (esomeprazole magnesium) in Massachusetts, A Class Action Lawsuit May Affect Your Rights. There is a class action lawsuit pending in Suffolk County Superior Court in the Commonwealth of Massachusetts ("Lawsuit"). The name of the Lawsuit is...

Horse Gold Unique Proprietary Formula Obliterates Gastric Pain in Horses Bradenton, FL (PRWEB) July 26, 2011 Horse Gold, makers of hyper-effective equine supplements created by horsemen for horsemen, officially released Gastromax3â„¢ paste, an affordable, once-a-day preventive anti-ulcer supplement for horses. Gastromax3â„¢ paste is formulated to prevent debilitating ulcers using omeprazole, a protein pump inhibitor that blocks the production of acid, plus supplemental...

In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA."GERD is a highly prevalent disorder caused by the reflux of gastric contents into the esophagus. It is a chronic, relapsing disease that negatively affects...

FRAZER, Pa., May 6, 2011 /PRNewswire/ -- At the Society of General Internal Medicine's 34th Annual Meeting in Phoenix, Ariz. today, Cephalon, Inc. (Nasdaq: CEPH) presented positive results from a phase IV trial of nearly 400 people with excessive sleepiness associated with shift work disorder. In the trial, NUVIGIL® (armodafinil) Tablets [C-IV] improved shift-workers' overall clinical condition late in their shifts (i.e., 4:00 a.m. to 8:00 a.m.), including the commute home, compared to...

FRAZER, Pa., April 21, 2011 /PRNewswire/ -- Cephalon, Inc. (NASDAQ: CEPH) today announced that it has filed a definitive Consent Revocation Statement with the Securities and Exchange Commission (SEC) urging shareholders to reject Valeant Pharmaceuticals International Inc.'s proposals to remove Cephalon's entire Board of Directors and replace them with nominees hand-picked by Valeant. Cephalon also mailed copies of the Statement to shareholders of record together with a WHITE consent...

HOUSTON, April 19, 2011 /PRNewswire/ -- An Ohio woman suffered bone deterioration and broken bones because of hidden risks with pharmaceutical giant AstraZeneca's acid reflux drug Nexium, The Gibson Law Firm alleges in a lawsuit filed today in Texas federal court. Filed in the U.S. District Court in Houston, the lawsuit alleges 58-year-old Ginny Begin, of Toledo, Ohio, suffered serious bone deterioration after taking Nexium on a daily basis between 2003 and early 2011. In March, the FDA...

MISSISSAUGA, Ontario, April 11, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today filed with the Securities and Exchange Commission a presentation in connection with its written consent solicitation to stockholders of Cephalon, Inc. (NASDAQ: CEPH) for removal of Cephalon's current Board of Directors and election of its seven nominees in their place. Valeant compares its $73.00 per share all-cash offer, which would deliver immediate and certain...